XSHE
000411
Market cap851mUSD
Oct 09, Last price
10.16CNY
1D
0.59%
1Q
9.13%
Name
Zhejiang Int'l Group Co.
Chart & performance
P/E
11.45
P/S
0.17
EPS
0.89
Div yield, %
3.79%
Shrs. gr., 5y
10.93%
Rev. gr., 5y
4.73%
Revenues
33.68b
+0.98%
Net income
501m
-4.62%
CFO
356m
-13.32%
Dividend
Jul 10, 20260.354 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1950, Zhejiang Int'l Group Co.,Ltd. is an enterprise based in Hangzhou, China, specializing in both the bulk distribution and direct sale of pharmaceutical products and medical instruments.
Key people
Jufang Jiang
Chairman of the Board · since 2018
Heng Wu
Chief Financial Officer · since 2012
Zhihu Bao
Deputy General Manager · since 2018
Minying Wu
Deputy General Manager · since 2018
Peihong Zhao
Deputy General Manager · since 2012
Jiang Tan
Secretary of the Board · since 2018
Qiwei Chen
Director · since 2012
Director · since 2019
Weihong Ge
Director · since 2018
Guoliang Luo
General Manager, Director · since 2018
Xiehe Zhu
Independent Director · since 2008
Headquarters & legal address
杭州市下城区东新路江南巷2号3幢
杭州市, ZJ 100000
CN
杭州市, ZJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||